Real Chemistry State Analysis State-by-State Medicaid Coverage of GLP-1 Weight Loss Medications (realchemistry.com, December 15, 2024, updated January 2, 2025) Detailed breakdown of which state Medicaid programs cover obesity GLP-1 drugs and spending data
Anatomic and functional brain imaging in Alzheimer's disease
Semaglutide, already approved by the FDA as a treatment for type 2 diabetes, is a synthetic version of the naturally occurring hormone GLP-1 and works on appetite centers in the brain and the gut, producing feelings of fullness
Ipamorelin has no marketing authorisation anywhere, so there is no regulatory label and no post-marketing pharmacovigilance database
Laser therapy is highly effective for stubborn age spots, deep pigmentation, and melasma